Literature DB >> 18254492

Serum immunoglobulin IgG subclass distribution of antibody responses to Yop proteins and lipopolysaccharide of Yersinia enterocolitica in patients with yersiniosis.

Waldemar Rastawicki1, Aleksandra Jakubczak.   

Abstract

To assess the humoral immunological responses at the IgG subclass level in yersiniosis specific antibody responses against lipopolysaccharide of Yersinia enterocolitica 03 (LPS) and Yersinia Yop proteins were analyzed by ELISA. Thirty five patients with arthritis and forty nine patients with uncomplicated yersiniosis were included in the study. Analysis of the IgG subclass responses to the LPS revealed that the subclass distribution for both groups of patients was IgG2>IgG1>IgG3. The concentration of IgG4 was below detection level. The predominant antibody responses to Yop proteins were IgG1>IgG3>IgG2>IgG4 but the frequency of detection of particular IgG subclass antibodies were dependent on the age of patients. Generally, the frequency of occurrence of IgG2 antibodies for Yop proteins of Yersinia together increased with age reaching its peak among individuals aged above 40 years. On the other hand, IgG1 for Yop proteins and IgG3 for Y. enterocolitica LPS were diagnosed more often in serum samples obtained from children than from adults. We also found significantly higher frequency of IgG4 to Yop proteins of Y. enterocolitica in men than in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18254492

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  2 in total

1.  Expression, purification, and characterization of the humoral immune response to recombinant MyfA protein of Yersinia enterocolitica.

Authors:  W Rastawicki; R Gierczyński
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-20       Impact factor: 3.267

Review 2.  Sexual dimorphism in bacterial infections.

Authors:  Edgar Ricardo Vázquez-Martínez; Elizabeth García-Gómez; Ignacio Camacho-Arroyo; Bertha González-Pedrajo
Journal:  Biol Sex Differ       Date:  2018-06-20       Impact factor: 5.027

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.